nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0939	0.142	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0939	0.142	CbGbCtD
Triazolam—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0704	0.107	CbGbCtD
Triazolam—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0677	0.103	CbGbCtD
Triazolam—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0472	0.0717	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0431	0.0654	CbGbCtD
Triazolam—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0431	0.0654	CbGbCtD
Triazolam—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0323	0.0491	CbGbCtD
Triazolam—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0296	0.045	CbGbCtD
Triazolam—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0295	0.0448	CbGbCtD
Triazolam—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0285	0.0432	CbGbCtD
Triazolam—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0275	0.0417	CbGbCtD
Triazolam—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0202	0.0307	CbGbCtD
Triazolam—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0126	0.0191	CbGbCtD
Triazolam—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0116	0.0175	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00788	0.012	CbGbCtD
Triazolam—GABRQ—nerve—peripheral nervous system neoplasm	0.00349	0.118	CbGeAlD
Triazolam—GABRR3—nerve—peripheral nervous system neoplasm	0.00349	0.118	CbGeAlD
Triazolam—GABRR2—nerve—peripheral nervous system neoplasm	0.00303	0.102	CbGeAlD
Triazolam—GABRR1—nerve—peripheral nervous system neoplasm	0.00292	0.0981	CbGeAlD
Triazolam—GABRG1—ganglion—peripheral nervous system neoplasm	0.00241	0.081	CbGeAlD
Triazolam—GABRA2—ganglion—peripheral nervous system neoplasm	0.00161	0.0542	CbGeAlD
Triazolam—GABRA6—brainstem—peripheral nervous system neoplasm	0.00104	0.035	CbGeAlD
Triazolam—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.000866	0.0291	CbGeAlD
Triazolam—GABRE—trigeminal ganglion—peripheral nervous system neoplasm	0.000785	0.0264	CbGeAlD
Triazolam—GABRB2—brainstem—peripheral nervous system neoplasm	0.000766	0.0258	CbGeAlD
Triazolam—TSPO—trigeminal ganglion—peripheral nervous system neoplasm	0.000732	0.0246	CbGeAlD
Triazolam—GABRA2—brainstem—peripheral nervous system neoplasm	0.0007	0.0236	CbGeAlD
Triazolam—TSPO—parotid gland—peripheral nervous system neoplasm	0.000691	0.0232	CbGeAlD
Triazolam—GABRA1—brainstem—peripheral nervous system neoplasm	0.000677	0.0228	CbGeAlD
Triazolam—GABRB3—trigeminal ganglion—peripheral nervous system neoplasm	0.000665	0.0224	CbGeAlD
Triazolam—TSPO—brainstem—peripheral nervous system neoplasm	0.000648	0.0218	CbGeAlD
Triazolam—GABRR2—cerebellum—peripheral nervous system neoplasm	0.000641	0.0216	CbGeAlD
Triazolam—GABRD—cerebellum—peripheral nervous system neoplasm	0.000536	0.018	CbGeAlD
Triazolam—GABRG1—cerebellum—peripheral nervous system neoplasm	0.000516	0.0174	CbGeAlD
Triazolam—GABRA6—cerebellum—peripheral nervous system neoplasm	0.000513	0.0173	CbGeAlD
Triazolam—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000505	0.00162	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.00161	CcSEcCtD
Triazolam—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00161	CcSEcCtD
Triazolam—GABRB1—cerebellum—peripheral nervous system neoplasm	0.000501	0.0168	CbGeAlD
Triazolam—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000499	0.0016	CcSEcCtD
Triazolam—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000498	0.0016	CcSEcCtD
Triazolam—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000497	0.0016	CcSEcCtD
Triazolam—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000495	0.00159	CcSEcCtD
Triazolam—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000495	0.00159	CcSEcCtD
Triazolam—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000493	0.00158	CcSEcCtD
Triazolam—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00158	CcSEcCtD
Triazolam—Oedema—Vincristine—peripheral nervous system neoplasm	0.000491	0.00158	CcSEcCtD
Triazolam—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000489	0.00157	CcSEcCtD
Triazolam—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000486	0.00156	CcSEcCtD
Triazolam—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000485	0.00156	CcSEcCtD
Triazolam—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00155	CcSEcCtD
Triazolam—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00155	CcSEcCtD
Triazolam—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00048	0.00154	CcSEcCtD
Triazolam—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000479	0.00154	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000478	0.00153	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000477	0.00153	CcSEcCtD
Triazolam—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000476	0.00153	CcSEcCtD
Triazolam—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000475	0.00153	CcSEcCtD
Triazolam—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000475	0.00153	CcSEcCtD
Triazolam—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000474	0.00152	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000474	0.00152	CcSEcCtD
Triazolam—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00047	0.00151	CcSEcCtD
Triazolam—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000469	0.00151	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000468	0.0015	CcSEcCtD
Triazolam—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000468	0.0015	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.0015	CcSEcCtD
Triazolam—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000464	0.00149	CcSEcCtD
Triazolam—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.00148	CcSEcCtD
Triazolam—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00148	CcSEcCtD
Triazolam—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00148	CcSEcCtD
Triazolam—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.00147	CcSEcCtD
Triazolam—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00146	CcSEcCtD
Triazolam—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000454	0.00146	CcSEcCtD
Triazolam—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00146	CcSEcCtD
Triazolam—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.00145	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000453	0.00145	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000452	0.00145	CcSEcCtD
Triazolam—GABRA4—cerebellum—peripheral nervous system neoplasm	0.000452	0.0152	CbGeAlD
Triazolam—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000451	0.00145	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000449	0.00144	CcSEcCtD
Triazolam—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000448	0.00144	CcSEcCtD
Triazolam—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000447	0.00144	CcSEcCtD
Triazolam—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000446	0.00143	CcSEcCtD
Triazolam—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000444	0.00143	CcSEcCtD
Triazolam—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000444	0.00143	CcSEcCtD
Triazolam—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000444	0.00143	CcSEcCtD
Triazolam—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00142	CcSEcCtD
Triazolam—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000441	0.00142	CcSEcCtD
Triazolam—Malaise—Etoposide—peripheral nervous system neoplasm	0.000439	0.00141	CcSEcCtD
Triazolam—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.00141	CcSEcCtD
Triazolam—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.0014	CcSEcCtD
Triazolam—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.0014	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000434	0.00139	CcSEcCtD
Triazolam—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000434	0.00139	CcSEcCtD
Triazolam—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000431	0.00138	CcSEcCtD
Triazolam—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00138	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000428	0.00137	CcSEcCtD
Triazolam—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000427	0.00137	CcSEcCtD
Triazolam—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000427	0.00137	CcSEcCtD
Triazolam—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000427	0.00137	CcSEcCtD
Triazolam—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000427	0.00137	CcSEcCtD
Triazolam—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000426	0.00137	CcSEcCtD
Triazolam—Headache—Topotecan—peripheral nervous system neoplasm	0.000424	0.00136	CcSEcCtD
Triazolam—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000424	0.00136	CcSEcCtD
Triazolam—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000423	0.00136	CcSEcCtD
Triazolam—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000423	0.00136	CcSEcCtD
Triazolam—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000423	0.00136	CcSEcCtD
Triazolam—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000422	0.00135	CcSEcCtD
Triazolam—Headache—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00135	CcSEcCtD
Triazolam—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00135	CcSEcCtD
Triazolam—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000421	0.00135	CcSEcCtD
Triazolam—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Triazolam—Constipation—Vincristine—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Triazolam—Pain—Vincristine—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Triazolam—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00135	CcSEcCtD
Triazolam—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000418	0.00134	CcSEcCtD
Triazolam—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.00134	CcSEcCtD
Triazolam—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000415	0.00133	CcSEcCtD
Triazolam—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000414	0.00133	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.00133	CcSEcCtD
Triazolam—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00041	0.00132	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000405	0.0013	CcSEcCtD
Triazolam—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000403	0.00129	CcSEcCtD
Triazolam—Nausea—Topotecan—peripheral nervous system neoplasm	0.000402	0.00129	CcSEcCtD
Triazolam—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000401	0.00129	CcSEcCtD
Triazolam—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000401	0.00129	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00128	CcSEcCtD
Triazolam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000399	0.00128	CcSEcCtD
Triazolam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000399	0.00128	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.00128	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00127	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000394	0.00127	CcSEcCtD
Triazolam—Nausea—Melphalan—peripheral nervous system neoplasm	0.000394	0.00127	CcSEcCtD
Triazolam—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00125	CcSEcCtD
Triazolam—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000388	0.00125	CcSEcCtD
Triazolam—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000388	0.00125	CcSEcCtD
Triazolam—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00124	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000384	0.00123	CcSEcCtD
Triazolam—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000379	0.00122	CcSEcCtD
Triazolam—GABRG2—cerebellum—peripheral nervous system neoplasm	0.000378	0.0127	CbGeAlD
Triazolam—GABRB2—cerebellum—peripheral nervous system neoplasm	0.000378	0.0127	CbGeAlD
Triazolam—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00121	CcSEcCtD
Triazolam—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000376	0.00121	CcSEcCtD
Triazolam—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.0012	CcSEcCtD
Triazolam—Pain—Cisplatin—peripheral nervous system neoplasm	0.000371	0.00119	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.00119	CcSEcCtD
Triazolam—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000366	0.00118	CcSEcCtD
Triazolam—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00117	CcSEcCtD
Triazolam—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000362	0.00116	CcSEcCtD
Triazolam—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00116	CcSEcCtD
Triazolam—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000358	0.00115	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000357	0.00115	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000354	0.00114	CcSEcCtD
Triazolam—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000353	0.00113	CcSEcCtD
Triazolam—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000352	0.00113	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000349	0.00112	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000349	0.00112	CcSEcCtD
Triazolam—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.00112	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000346	0.00111	CcSEcCtD
Triazolam—GABRA2—cerebellum—peripheral nervous system neoplasm	0.000345	0.0116	CbGeAlD
Triazolam—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000343	0.0011	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00109	CcSEcCtD
Triazolam—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00109	CcSEcCtD
Triazolam—Pain—Etoposide—peripheral nervous system neoplasm	0.00034	0.00109	CcSEcCtD
Triazolam—Constipation—Etoposide—peripheral nervous system neoplasm	0.00034	0.00109	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.00109	CcSEcCtD
Triazolam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00108	CcSEcCtD
Triazolam—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000336	0.00108	CcSEcCtD
Triazolam—GABRA1—cerebellum—peripheral nervous system neoplasm	0.000334	0.0112	CbGeAlD
Triazolam—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000328	0.00105	CcSEcCtD
Triazolam—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.00105	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000325	0.00104	CcSEcCtD
Triazolam—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000325	0.00104	CcSEcCtD
Triazolam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.00104	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.00104	CcSEcCtD
Triazolam—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000321	0.00103	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00032	0.00103	CcSEcCtD
Triazolam—TSPO—cerebellum—peripheral nervous system neoplasm	0.00032	0.0107	CbGeAlD
Triazolam—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00102	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00101	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.00101	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000314	0.00101	CcSEcCtD
Triazolam—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000312	0.001	CcSEcCtD
Triazolam—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000311	0.001	CcSEcCtD
Triazolam—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000309	0.000993	CcSEcCtD
Triazolam—Headache—Vincristine—peripheral nervous system neoplasm	0.000307	0.000987	CcSEcCtD
Triazolam—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.000971	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000971	CcSEcCtD
Triazolam—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000297	0.000953	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000293	0.000941	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000939	CcSEcCtD
Triazolam—Nausea—Vincristine—peripheral nervous system neoplasm	0.000292	0.000936	CcSEcCtD
Triazolam—GABRB3—cerebellum—peripheral nervous system neoplasm	0.00029	0.00976	CbGeAlD
Triazolam—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000285	0.000916	CcSEcCtD
Triazolam—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000281	0.000903	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.000898	CcSEcCtD
Triazolam—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000276	0.000886	CcSEcCtD
Triazolam—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000273	0.000878	CcSEcCtD
Triazolam—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000877	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000272	0.000873	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000869	CcSEcCtD
Triazolam—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000864	CcSEcCtD
Triazolam—Tension—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00086	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000859	CcSEcCtD
Triazolam—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000852	CcSEcCtD
Triazolam—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000263	0.000844	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000843	CcSEcCtD
Triazolam—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000258	0.000828	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000814	CcSEcCtD
Triazolam—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000253	0.000812	CcSEcCtD
Triazolam—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000811	CcSEcCtD
Triazolam—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000806	CcSEcCtD
Triazolam—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00025	0.000804	CcSEcCtD
Triazolam—Headache—Etoposide—peripheral nervous system neoplasm	0.000249	0.0008	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000799	CcSEcCtD
Triazolam—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000796	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000794	CcSEcCtD
Triazolam—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000791	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000788	CcSEcCtD
Triazolam—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000786	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00078	CcSEcCtD
Triazolam—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000775	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000771	CcSEcCtD
Triazolam—Nausea—Etoposide—peripheral nervous system neoplasm	0.000236	0.000758	CcSEcCtD
Triazolam—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000757	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000753	CcSEcCtD
Triazolam—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000746	CcSEcCtD
Triazolam—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000746	CcSEcCtD
Triazolam—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000744	CcSEcCtD
Triazolam—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000738	CcSEcCtD
Triazolam—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000732	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00073	CcSEcCtD
Triazolam—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000728	CcSEcCtD
Triazolam—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000722	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000717	CcSEcCtD
Triazolam—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000716	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000713	CcSEcCtD
Triazolam—Shock—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000704	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.0007	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000698	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000692	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000691	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000688	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000682	CcSEcCtD
Triazolam—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000682	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000676	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000668	CcSEcCtD
Triazolam—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000662	CcSEcCtD
Triazolam—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000651	CcSEcCtD
Triazolam—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000647	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000646	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000643	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00064	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000638	CcSEcCtD
Triazolam—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000636	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000631	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000622	CcSEcCtD
Triazolam—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000617	CcSEcCtD
Triazolam—Pain—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000612	CcSEcCtD
Triazolam—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000612	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000599	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000595	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00059	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00059	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000589	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000585	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000576	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000571	CcSEcCtD
Triazolam—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000566	CcSEcCtD
Triazolam—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000566	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000566	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000546	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000541	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000527	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000523	CcSEcCtD
Triazolam—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000513	CcSEcCtD
Triazolam—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000506	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00049	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000488	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000475	CcSEcCtD
Triazolam—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000473	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000468	CcSEcCtD
Triazolam—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000455	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000453	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000451	CcSEcCtD
Triazolam—Headache—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000448	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000438	CcSEcCtD
Triazolam—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000425	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000421	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000417	CcSEcCtD
Triazolam—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000415	CcSEcCtD
Triazolam—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000393	CcSEcCtD
